Xuefeng Mei
Overview
Explore the profile of Xuefeng Mei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jiang Y, Cheng Y, Xia M, Zhang B, Ding Q, Lu L, et al.
Pharmaceutics
. 2022 Nov;
14(11).
PMID: 36432669
Dehydroepiandrosterone (DHEA) is an FDA-approved food supplement used as an assisted reproductive sex hormone. The bioavailability is severely limited by its poor solubility (23 µg/mL). Herein, we aimed to modulate...
12.
Xiao F, Cheng Y, Wang J, Wang D, Zhang Y, Chen K, et al.
Pharmaceutics
. 2022 Oct;
14(10).
PMID: 36297633
Bexarotene (BEX) was approved by the FDA in 1999 for the treatment of cutaneous T-cell lymphoma (CTCL). The poor aqueous solubility causes the low bioavailability of the drug and thereby...
13.
Yang Z, Yang Y, Xia M, Dai W, Zhu B, Mei X
Int J Pharm
. 2022 Jan;
614:121460.
PMID: 35026315
Abiraterone acetate (ABA), the first-line drug for the treatment of metastatic castration resistant prostate cancer (mCRPC), is administered at a high daily dosage of 1000 mg due to its poor...
14.
Cheng Y, Rong X, Xia M, Zhang Z, Wang J, Mei X
Int J Pharm
. 2021 Oct;
610:121222.
PMID: 34699948
Isotretinoin is the first-line drug for treatment of severe acne. Only one polymorph was reported even though it has been launched for nearly 40 years, and its clinic application was...
15.
Deng W, Du X, Zhou W, Mei X, Tian Y, Chen L, et al.
Ann Palliat Med
. 2021 Oct;
10(9):9870-9878.
PMID: 34628913
Background: Prostatitis seriously endangers the health of men. While they have been widely used in recent years, there remains a lack of systematic evaluation of the clinical efficacy of α-receptor...
16.
Tian Y, Gao P, Dai D, Chen L, Chu X, Mei X
Cell Cycle
. 2021 Jul;
20(16):1589-1602.
PMID: 34288821
Bladder cancer (BLCA) is a common malignant urothelial cancer in the world. Although circular RNAs (circRNAs) involve in regulating BLCA progression, the role of a novel circular RNA circSETD3 in...
17.
Yang J, Gong C, Zhao J, Chen L, Mei X, Li G, et al.
Transl Androl Urol
. 2020 Nov;
9(5):2242-2250.
PMID: 33209689
Background: Clear cell renal carcinoma (CCRCC) is a multigene-related tumor. The aim of the present study was to analyze the expression of breast cancer 1-associated protein 1 (BAP1), Ki-67, and...
18.
Zhu B, Zhang Q, Lu L, Bao J, Rong X, Wang J, et al.
Int J Pharm
. 2020 Nov;
592:120057.
PMID: 33171264
d-α-tocopherol (d-αToc), the most biologically active form of natural Vitamin E, is oily in appearance and unstable to oxygen. Esterification and encapsulation are generally needed to stabilize and solidify d-αToc...
19.
Guo Q, Zhang T, Wang N, Xia Y, Zhou Z, Wang J, et al.
J Agric Food Chem
. 2020 Oct;
68(42):11875-11876.
PMID: 33026806
No abstract available.
20.
Guo C, Zhang Q, Zhu B, Zhu B, Zhou W, Ren G, et al.
Acta Crystallogr B Struct Sci Cryst Eng Mater
. 2020 Aug;
75(Pt 5):839-844.
PMID: 32830763
A donor-π-acceptor fluorescent dye, 4-[N,N-di(4-phenyl)amino]benzaldehyde 4-chlorobenzoyl hydrazone (TPA-CBH), based on a triphenylamine derivative (TPA) and 4-chlorobenzoyl hydrazine (CBH) was designed and synthesized. The optical properties of this luminogen were investigated...